Job opportunity
In the field of rare diseases, true leadership extends beyond driving performance; it embodies a commitment to driving purpose. In this pivotal role, you will shape the commercial strategy for our Rare Disease portfolio, creating an impact that genuinely transforms lives.
As a Business Unit Director, you will lead the identification, development, and implementation of business opportunities that empower Novo Nordisk Switzerland to strengthen its leadership in Rare Diseases. You will nurture the potential of our employees and embody Novo Nordisk’s vision, values, and commitments.
The Novo Nordisk Swiss Affiliate comprises a team of 100 highly engaged and skilled individuals dedicated to making Switzerland healthier by providing innovative solutions to those in need, partnering with society for the benefit of the most vulnerable, and delivering excellence and innovation in execution.
The Rare Disease team operates within this dynamic organization and consists of highly skilled, ambitious professionals focused on results and committed to the business ethics and values of Novo Nordisk. As a Business Unit Director for Rare Disease, you will report to the General Manager of Switzerland and be part of the affiliate leadership team.
As a natural leader, you demonstrate proven ownership and accountability. You are an effective collaborator and communicator, skilled at engaging with a diverse range of internal and external stakeholders. Your entrepreneurial mindset allows you to think outside the box. Below are some key qualifications:
Every day, we pursue solutions that combat serious chronic diseases. Approaching our work with an unconventional spirit, unwavering determination, and constant curiosity, we have built a unique company over the past 100 years. Here, a collective passion for our purpose, mutual respect, and a willingness to go beyond conventional boundaries yield extraordinary results.
Apply online using the form below. Please note that only applications matching the job profile will be considered.